| 000 | 01599 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517040633.0 | ||
| 264 | 0 | _c20160222 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a1095-8673 | ||
| 024 | 7 |
_a10.1016/j.jss.2015.04.035 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXu, Li | |
| 245 | 0 | 0 |
_aLong-term therapy with sorafenib is associated with pancreatic atrophy. _h[electronic resource] |
| 260 |
_bThe Journal of surgical research _cDec 2015 |
||
| 300 |
_a314-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAtrophy _xchemically induced |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
| 650 | 0 | 4 |
_aChina _xepidemiology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNiacinamide _xadministration & dosage |
| 650 | 0 | 4 |
_aPancreas _xpathology |
| 650 | 0 | 4 |
_aPancreatic Diseases _xchemically induced |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aZhou, Dong-Sheng | |
| 700 | 1 | _aZhao, Jing | |
| 700 | 1 | _aSpolverato, Gaya | |
| 700 | 1 | _aZhang, Yao-Jun | |
| 700 | 1 | _aLi, Sheng-Ping | |
| 700 | 1 | _aChen, Min-Shan | |
| 700 | 1 | _aPawlik, Timothy M | |
| 773 | 0 |
_tThe Journal of surgical research _gvol. 199 _gno. 2 _gp. 314-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jss.2015.04.035 _zAvailable from publisher's website |
| 999 |
_c25021355 _d25021355 |
||